Get the Stockscreener App
11.59
0.09%
0.010
Overview
News
Price History
Option Chain
Financials
Discussions
Forecast
Stock Split
Dividend History
Dentsply Sirona Inc stock is traded at $11.59, with a volume of 2.71M.
It is up +0.09% in the last 24 hours and down -8.74% over the past month.
Dentsply Sirona is one of the world's largest manufacturers of dental equipment and supplies. It is a result of a merger of equals in 2016 between Dentsply International (dental consumables and lab products) and Sirona Dental Systems (technologically advanced dental equipment). The firm's wide portfolio consists of dental consumables, lab products, CAD/CAM and imaging technology, medical devices, and specialty products in orthodontics, endodontics, and implantation. It distributes two-thirds of its dental consumables, technology, and equipment through third-party distributors. The remaining portfolio is sold to labs and offices through the firm's salesforce or directly to consumers (such as the Byte clear aligner).
See More
Previous Close:
$11.58
Open:
$11.5
24h Volume:
2.71M
Relative Volume:
0.48
Market Cap:
$2.31B
Revenue:
$3.68B
Net Income/Loss:
$-627.00M
P/E Ratio:
-3.6821
EPS:
-3.1477
Net Cash Flow:
$104.00M
1W Performance:
-4.37%
1M Performance:
-8.74%
6M Performance:
-10.50%
1Y Performance:
-16.44%
1-Day Range:
$11.46
$11.88
1-Week Range:
$11.21
$12.12
52-Week Range:
$9.405
$14.86
Dentsply Sirona Inc Stock (XRAY) Company Profile
Name
Dentsply Sirona Inc
Sector
Industry
Phone
844-546-3722
Address
13320 BALLANTYNE CORPORATE PLACE, CHARLOTTE, NC
Compare XRAY vs ISRG, BDX, ALC, RMD, MDLN
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
XRAY
Dentsply Sirona Inc
|
11.59 | 2.27B | 3.68B | -627.00M | 104.00M | -3.1477 |
ISRG
Intuitive Surgical Inc
|
394.51 | 141.76B | 11.03B | 3.16B | 3.22B | 8.7251 |
BDX
Becton Dickinson Co
|
183.40 | 50.00B | 21.37B | 1.41B | 3.07B | 3.9437 |
ALC
Alcon Inc
|
74.25 | 35.57B | 10.63B | 819.00M | 1.59B | 1.6577 |
RMD
Resmed Inc
|
224.46 | 32.78B | 5.54B | 1.52B | 1.74B | 10.37 |
MDLN
Medline Inc
|
35.74 | 31.15B | 29.14B | 1.07B | 1.05B | 1.1956 |
Dentsply Sirona Inc Stock (XRAY) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Apr-15-26 | Initiated | Citigroup | Sell |
| Feb-19-26 | Upgrade | BofA Securities | Neutral → Buy |
| Dec-09-25 | Initiated | Barclays | Underweight |
| Nov-07-25 | Downgrade | William Blair | Outperform → Mkt Perform |
| Apr-15-25 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Mar-13-25 | Downgrade | Needham | Buy → Hold |
| Feb-14-25 | Initiated | Wells Fargo | Equal Weight |
| Jan-23-25 | Downgrade | Jefferies | Buy → Hold |
| Jan-07-25 | Downgrade | Evercore ISI | Outperform → In-line |
| Dec-04-24 | Initiated | Mizuho | Neutral |
| Nov-07-24 | Downgrade | Leerink Partners | Outperform → Market Perform |
| Oct-25-24 | Reiterated | Needham | Buy |
| Aug-20-24 | Reiterated | Needham | Buy |
| Feb-26-24 | Initiated | Leerink Partners | Outperform |
| Nov-16-23 | Initiated | Needham | Buy |
| Nov-10-23 | Upgrade | William Blair | Mkt Perform → Outperform |
| Jan-12-23 | Upgrade | William Blair | Underperform → Mkt Perform |
| Aug-05-22 | Downgrade | William Blair | Mkt Perform → Underperform |
| Jun-02-22 | Upgrade | UBS | Neutral → Buy |
| Apr-20-22 | Downgrade | Piper Sandler | Overweight → Neutral |
| Apr-20-22 | Downgrade | William Blair | Outperform → Mkt Perform |
| Apr-19-22 | Downgrade | BofA Securities | Buy → Neutral |
| Apr-19-22 | Downgrade | Robert W. Baird | Outperform → Neutral |
| Jan-31-22 | Initiated | Morgan Stanley | Overweight |
| Oct-01-21 | Resumed | Credit Suisse | Outperform |
| Aug-09-21 | Reiterated | H.C. Wainwright | Neutral |
| Aug-06-21 | Reiterated | Barrington Research | Outperform |
| Aug-05-21 | Resumed | Credit Suisse | Outperform |
| Mar-02-21 | Upgrade | Barrington Research | Mkt Perform → Outperform |
| Mar-02-21 | Reiterated | H.C. Wainwright | Neutral |
| Jan-05-21 | Reiterated | H.C. Wainwright | Neutral |
| Dec-18-20 | Downgrade | Stifel | Buy → Hold |
| Nov-17-20 | Downgrade | Barclays | Equal Weight → Underweight |
| Nov-09-20 | Reiterated | H.C. Wainwright | Neutral |
| Oct-22-20 | Upgrade | Guggenheim | Neutral → Buy |
| Aug-10-20 | Reiterated | H.C. Wainwright | Neutral |
| Jun-16-20 | Initiated | Piper Sandler | Overweight |
| Jun-15-20 | Reiterated | H.C. Wainwright | Neutral |
| May-27-20 | Upgrade | Evercore ISI | In-line → Outperform |
| May-11-20 | Downgrade | Barrington Research | Outperform → Mkt Perform |
| Apr-24-20 | Reiterated | H.C. Wainwright | Neutral |
| Apr-08-20 | Upgrade | Robert W. Baird | Neutral → Outperform |
| Apr-07-20 | Downgrade | Goldman | Buy → Neutral |
| Apr-02-20 | Upgrade | Wolfe Research | Peer Perform → Outperform |
| Mar-03-20 | Reiterated | H.C. Wainwright | Neutral |
| Feb-19-20 | Reiterated | Stifel | Buy |
| Dec-11-19 | Downgrade | JP Morgan | Overweight → Neutral |
| Aug-02-19 | Upgrade | Wellington Shields | Hold → Gradually Accumulate |
| Jul-26-19 | Initiated | Evercore ISI | In-line |
| Jul-09-19 | Reiterated | H.C. Wainwright | Neutral |
| May-30-19 | Initiated | Wolfe Research | Peer Perform |
View All
Dentsply Sirona Inc Stock (XRAY) Latest News
The 5 Most Interesting Analyst Questions From Dentsply Sirona’s Q2 Earnings Call - Yahoo Finance
Dentsply Sirona (XRAY): Southpoint reports 7M-share, 3.5% ownership in 13G/A - Stock Titan
Dentsply Sirona (XRAY) Q2 2026 Earnings Call Transcript - The Globe and Mail
Is DENTSPLY SIRONA’s (XRAY) Steady Buyback and Reaffirmed Outlook Reframing Its Risk‑Reward Profile? - simplywall.st
DENTSPLY SIRONA (XRAY) gains AQR Capital as 5.22% beneficial owner - Stock Titan
DS World Las Vegas 2026 connects clinical and laboratory education - Dental Tribune US
DENTSPLY SIRONA (XRAY) CFO awarded 104,200 stock options and 24,014 RSUs - Stock Titan
Pacer Advisors Inc. Has $266,000 Stake in DENTSPLY SIRONA Inc. $XRAY - MarketBeat
DENTSPLY SIRONA (XRAY) SVP Frohning reports 802 tax-withheld shares - Stock Titan
XRAY Q2 Deep Dive: Turnaround Progress Slowed by Market and Segment Headwinds - Yahoo Finance
DENTSPLY SIRONA (XRAY): Navigating Challenges With A 17.66% Potential Upside - directorstalkinterviews.com
Why Dentsply Sirona (XRAY) Stock Is Trading Lower Today - Yahoo! Finance Canada
Dentsply Sirona Earnings: Weak Recovery Momentum Unchanged as Soft Volume Weighs on Results - Morningstar
Empowered Funds LLC Grows Stake in DENTSPLY SIRONA Inc. $XRAY - MarketBeat
Dentsply Sirona (XRAY) Stock Drops As Revenue Weakens Despite Profit Rebound - Sahm
DENTSPLY SIRONA Inc. (NASDAQ:XRAY) Receives Average Recommendation of "Hold" from Analysts - MarketBeat
Form 8K Dentsply Sirona Inc For: 7 August By Investing.com - Investing.com Nigeria
DENTSPLY SIRONA Q2 Earnings Call Highlights - MarketBeat
1% Undervalued? DENTSPLY SIRONA (XRAY) As Earnings Test Its Recovery Story - Yahoo Finance
Dentsply Sirona Reports $898 Million in Net Sales for Second Quarter 2026 - Orthodontic Products
Dentsply's Full Recovery Timeline Looks Uncertain as Tough Market and Competition Put Pressure - Morningstar
XRAY Stock Falls Despite Q2 Earnings Beat, Wellspect Drives Sales - Yahoo Finance
DENTSPLY SIRONA (NASDAQ:XRAY) Trading Down 8.4%Here's What Happened - MarketBeat
A Quick Look at Today's Ratings for Dentsply Sirona(XRAY.US), With a Forecast Between $9 to $15 - Moomoo
DENTSPLY SIRONA Inc. Q2 2026 Earnings Call Summary - Yahoo Finance
DENTSPLY SIRONA Inc. Stock 12‑Month Price Target Raised to $13.7, Implies 4% Upside - TradingView
DENTSPLY SIRONA Inc. 2026 Q2ResultsEarnings Call Presentation (NASDAQ:XRAY) 2026-08-06 - Seeking Alpha
Earnings call transcript: DENTSPLY Sirona posts slight q2 2026 revenue beat, shares fall - Investing.com
DENTSPLY SIRONA (NASDAQ:XRAY) Issues Earnings Results - MarketBeat
DENTSPLY SIRONA (NASDAQ:XRAY) Releases FY 2026 Earnings Guidance - MarketBeat
Dentsply International (XRAY) Beats Q2 Earnings and Revenue Estimates - finance.yahoo.com
Transcript : DENTSPLY SIRONA Inc., Q2 2026 Earnings Call, Aug 06, 2026 - marketscreener.com
DENTSPLY SIRONA Inc. 2026: Revenue $898M, EPS $0.18— 10-Q Summary - TradingView
DENTSPLY SIRONA Inc. reports results for the quarter ended June 30Earnings Summary - TradingView
[10-Q] DENTSPLY SIRONA Inc. Quarterly Earnings Report - Stock Titan
Tranche Update on DENTSPLY SIRONA Inc.'s Equity Buyback Plan announced on March 16, 2005. - marketscreener.com
DENTSPLY SIRONA ($XRAY) Releases Q2 2026 Earnings, Stock Rises - quiverquant.com
Dentsply Sirona (NASDAQ:XRAY) Beats Q2 CY2026 Sales Expectations - Yahoo Finance
Earnings Flash (XRAY) DENTSPLY SIRONA Inc. Reports Q2 Revenue $898.0M, vs. FactSet Est of $889.9M - marketscreener.com
DENTSPLY SIRONA (XRAY): First Eagle discloses 851,347-share position in 13G/A - Stock Titan
Earnings Flash (XRAY) DENTSPLY SIRONA Inc. Posts Q2 Adjusted EPS $0.52 per Share - marketscreener.com
Dentsply Sirona Reports Second Quarter 2026 Results - marketscreener.com
BRIEF-Dentsply Sirona Q2 Revenue USD 898 Million Vs. IBES Estimate USD 889.8 Million - TradingView
DENTSPLY SIRONA Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 - marketscreener.com
Dentsply Sirona investors brace for earnings amid Medline threat By Investing.com - Investing.com Nigeria
Expanded Medline Sinclair Tech Distribution in Canada Could Be A Game Changer For DENTSPLY SIRONA (XRAY) - simplywall.st
Arkadios Wealth Advisors Purchases New Stake in DENTSPLY SIRONA Inc. $XRAY - MarketBeat
Dental products manufacturer keeps 2026 sales outlook at $3.5B-$3.6B - Stock Titan
Earnings To Watch: Dentsply Sirona (XRAY) Reports Q2 Results Tomorrow - The Globe and Mail
Dentsply Sirona’s Endo Forum 2026 explores advances in endodontic care - Dental Tribune US
DENTSPLY SIRONA to Post Q2 Earnings: What's in Store for the Stock? - Yahoo Finance
Dentsply Sirona Inc Stock (XRAY) Financials Data
Revenue
Net Income
Cash Flow
EPS
2.90%
1.18%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):